Leiderman Elisabeth bought AUTL
June 29, 2026 · Form 4 insider transaction
Leiderman Elisabeth bought 47,500 shares of Autolus Therapeutics plc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
47,500
Price
$0.00
Total value
N/A
InsiderLeiderman Elisabeth
Role—
SecurityShare Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 29, 2026
Filing dateJuly 1, 2026
Shares owned after47,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Share options vest in twelve equal monthly installments commencing on July 29, 2026.